The current JATT market cap is 355.73M. The company's latest EPS is USD -1.5884 and P/E is -0.77.
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 |
Operating Income | -888k | -2.68M | -62.64M |
Net Income | 6.85M | 3.55M | -69.24M |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Assets | 140.55M | 141.51M | 100.84M |
Total Liabilities | 10.35M | 7.76M | 21.29M |
Total Equity | -9.18M | -7.63M | 60.87M |
Market Cap | 355.73M |
Price to Earnings Ratio | -0.77 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.54 |
Price to Book Ratio | 0.67 |
Dividend Yield | - |
Shares Outstanding | 43.59M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.43 (5%) |
Company Name | JATT Acquisition Corp |
Address |
po box 309, ugland house grand cayman KY1 1114 |
Website | https://zurabio.com |
Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions